Drug factory · FDA FEI 3011158222
Contract Pharmaceuticals Limited Canada
2145 Meadowpine Blvd., Mississauga, Canada
Problems found, fixed voluntarily at FDA's last inspection, Sep 13, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2015: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Capsaicin | Tests it | Averitas Pharma, Inc. | 72512-928, 72512-929, 72512-930 |
| Difamilast | Tests it | Acrotech Biopharma Inc | 72893-017 |
| Testosterone | Tests it | Upsher-Smith Laboratories, Inc. | 0245-0871, 0245-0872 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 13, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Aug 17, 2018 | No problems found | Drug Quality Assurance | — |
| Jul 14, 2015 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.